A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brenda LaTowsky, MD
Investigate MD
Principal Investigator - Brian Jiang, MD
University of California, San Diego
Principal Investigator - David Goldberg
Schweiger Dermatology Group
Principal Investigator - Edward Primka, MD
Dermatology Associates of Knoxville
Principal Investigator - Girish Munavalli, MD
Dermatology, Laser and Vein Specialists of the Carolinas
Principal Investigator - Kenneth Beer, MD
Research Institute of the Southeast LLC
Principal Investigator - Mark Ling, MD
Medaphase Inc
Principal Investigator - Megan Couvillion, MD
SBA Dermatology
Principal Investigator - Michael Gold, MD
Tennessee Clinical Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Investigate Md
Scottsdale, Arizona, United States
- Center for Clinical and Cosmetic Research
Aventura, Florida, United States
- Research Institute of the Southeast Llc
West Palm Beach, Florida, United States
- Dermatology, Laser and Vein Specialists of the Carolinas
Charlotte, North Carolina, United States
- Dermatology Associates of Knoxville
Knoxville, Tennessee, United States
- Tennessee Clinical Research
Nashville, Tennessee, United States
- Austin Institute for Clinical Research
Pflugerville, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 May 2021
- Primary completion
- 24 Aug 2022
- Completion
- 6 Dec 2022
- Last update posted
- 18 Mar 2024
- Registered enrollment
- 44
- Registry id
- NCT04844983
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.